James L. Murray

Statistics

Publications

Citations

709

H-Index

Active since

1977

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Breast Cancer Care

University of Louisville

James Graham Brown Foundation

James L. Murray is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pharmacokinetics of anticancer agents.

ORCID

Publications per year

1977–2022

Publications

Lipid Bilayer Simulations of CXCR4 with Inverse Agonists and Weak Partial Agonists

John O. Trent, Zixuan Wang, James L. Murray et al. · Journal of Biological Chemistry · 2003 · 115 citations · Full text

Medicine, Biochemistry, Pharmacology +16

Phase II radioimmunotherapy trial with131I-CC49 in colorectal cancer

James L. Murray, Daniel J. Macey, Leela P. Kasi et al. · Cancer · 1994 · 88 citations

Medicine, Nuclear Medicine, Oncology +16

Phase I and II Study of Exisulind in Combination With Capecitabine in Patients With Metastatic Breast Cancer

Lajos Pusztai, Jim Hou Zhen, Banu Arun et al. · Journal of Clinical Oncology · 2003 · 59 citations

Medicine, Oncology, Pharmacology +17

Metastatic Tumor to the Retina and Vitreous Cavity from Primary Melanoma of the Skin

Dennis M. Robertson, C. P. Wilkinson, James L. Murray et al. · Ophthalmology · 1981 · 57 citations

Medicine, Oncology, Ophthalmology +16

Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization 1 1Edited by I. Wilson

Qinxue Hu, John O. Trent, Georgia D. Tomaras et al. · Journal of Molecular Biology · 2000 · 57 citations

Life Sciences, Molecular Biology, Molecular Virology +1

1–5 of 18